Macrobid is a brand name for nitrofurantoin, an antibiotic primarily used to treat and prevent urinary tract infections (UTIs) [1].
What kind of antibiotic is Macrobid?
Macrobid belongs to the nitrofurantoin class of antibiotics. It works by damaging bacterial DNA and interfering with various metabolic processes essential for bacterial survival [1].
What conditions does Macrobid treat?
Macrobid is prescribed to treat acute infections of the lower urinary tract, such as cystitis, and is also used for long-term prevention of recurrent UTIs [1].
How does Macrofurantoin work to fight UTIs?
Nitrofurantoin, the active ingredient in Macrobid, is concentrated in the urine. Once in the urinary tract, it is converted by bacteria into compounds that disrupt bacterial cell wall formation and inhibit key metabolic enzymes, ultimately killing the bacteria [1].
When does the patent for Macrobid expire?
Information on specific patent expiry dates for Macrobid can be found on DrugPatentWatch.com. Generally, brand-name drugs have patent protection that eventually expires, allowing for generic versions to be developed and marketed [2].
Who makes Macrobid?
The manufacturer of Macrobid has changed over time. Currently, it is marketed by various pharmaceutical companies, with West-Ward Pharmaceuticals being a prominent distributor [1].
What are the potential side effects of Macrobid?
Common side effects of Macrobid can include nausea, vomiting, diarrhea, headache, and dizziness. More serious, though less common, side effects can involve lung reactions (cough, shortness of breath) and liver problems [1]. Patients should discuss any concerns with their healthcare provider.